C-C Chemokine Receptor Type 9 (CCR9) Antibody

Este producto es parte de CCR - C-C chemokine receptor type
C-C Chemokine Receptor Type 9 (CCR9) Antibody
299€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
C-C Chemokine Receptor Type 9 (CCR9) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx243073
Tested Applications
ELISA, WB, IF/ICC, IP

Description

C-C Chemokine Receptor Type 9 (CCR9) Antibody is a Monoclonal Antibody against CCR9.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: C-C Chemokine Receptor Type 9 (CCR9)
Immunogen: A synthesized peptide derived from Human CCR9.
Host
Rabbit
Reactivity
Human, Mouse
Assay Type
Concentration: 1.5 mg/ml
Recommended Dilution
WB: 1/500 - 1/5000, IF/ICC: 1/20 - 1/200, IP: 1/200 - 1/1000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG
Clone ID
V147
Expression
Recombinant
Purification
Purified by affinity chromatography.
Size 1
50 µl
Size 2
100 µl
Form
Liquid
Tested Applications
ELISA, WB, IF/ICC, IP
Buffer
PBS, pH 7.4, 150 mM NaCl, 0.02% sodium azide and 50% glycerol.
Availability
Shipped within 1-2 weeks.
Storage
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P51686
Alias
CCR9,C-C motif chemokine receptor 9,CC-CKR-9,CDw199,GPR-9-6,GPR28,
Background
Antibody anti-CCR9
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

C-C Chemokine Receptor Type 9 (CCR9) is a G-protein-coupled receptor highly expressed on T lymphocytes within the gut-associated lymphoid tissue (GALT) and plays a critical role in mucosal immunity. CCR9 binds its ligand CCL25 (TECK), which is predominantly expressed in the small intestine, guiding the homing of T cells to the intestinal epithelium. This receptor-ligand interaction is crucial for maintaining intestinal immune surveillance and protecting the gut from pathogens. CCR9 is particularly important for the migration of T-helper 1 (Th1) cells and memory T cells into the small intestine, where they contribute to immune homeostasis. However, CCR9 is also implicated in inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, where excessive T-cell migration to the gut exacerbates inflammation and tissue damage. In cancer, CCR9 is overexpressed in certain types of T-cell leukemias and gastrointestinal tumors, where it contributes to tumor growth and metastasis by enhancing immune cell recruitment. CCR9 has also been explored as a potential therapeutic target for intestinal inflammation and gastrointestinal cancers. Blocking CCR9-CCL25 signaling with targeted therapies, such as small-molecule inhibitors, has shown promise in reducing gut inflammation and preventing lymphocyte migration in preclinical and clinical studies. This makes CCR9 a pivotal player in intestinal immunity, chronic inflammation, and tumor biology.

Productos relacionados

abx027644

C-C Chemokine Receptor Type 9 (CCR9) Antibody

The protein encoded by this gene is a member of the beta chemokine receptor family. It is predicted to be a seven transm…

Ver producto
abx212848

C-C Chemokine Receptor Type 9 (CCR9) Antibody

CCR9 Antibody is a Rabbit Polyclonal against CCR9.…

Ver producto
abx212849

C-C Chemokine Receptor Type 9 (CCR9) Antibody

CCR9 Antibody is a Rabbit Polyclonal against CCR9.…

Ver producto